3 Results for "

TOV21G cells

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "TOV21G cells" in MCE Product Catalog:

13
13 Cited Publications
Cat. No.: HY-15650
CAS No.: 1561178-17-3
Purity:  99.68%
Research Areas:  

Cancer

SGC0946 is a selective DOT1L inhibitor with an IC50 value of 0.3 nM. By inhibiting DOT1L, SGC0946 can induce G1 phase arrest, suppress cell self-renewal and metastatic potential, and induce cell differentiation in cancer cells. SGC0946 can be used in the research of tumors such as leukemia and breast cancer, and also serves as a probe to further investigate the cellular mechanisms of DOT1L in normal and diseased cells .
loading...
    loading...
Cat. No.: HY-175842
CAS No.: 3030279-55-8
Target:  

PROTACs CDK

Research Areas:  

Cancer

PROTAC CDK2 Degrader-2 is an orally active CDK2 PROTAC degrader, with DC50 values of 13 nM (MKN1cells) and 17 nM (TOV21G cells). PROTAC CDK2 Degrader-2 induces G1 phase arrest in MKN1 cells. PROTAC CDK2 Degrader-2 achieves tumor stasis in HCC1569 (CCNE1-amplified) xenograft models. PROTAC CDK2 Degrader-2 can be used for the study of CCNE1-amplified cancers .
loading...
    loading...
Cat. No.: HY-15650A
Research Areas:  

Cancer

SGC0946 TFA is a selective DOT1L inhibitor with an IC50 value of 0.3 nM. By inhibiting DOT1L, SGC0946 TFA can induce G1 phase arrest, suppress cell self-renewal and metastatic potential, and induce cell differentiation in cancer cells. SGC0946 TFA can be used in the research of tumors such as leukemia and breast cancer, and also serves as a probe to further investigate the cellular mechanisms of DOT1L in normal and diseased cells .
loading...
    loading...